(NASDAQ: ICUI) Icu Medical's forecast annual revenue growth rate of 3.83% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Icu Medical's revenue in 2026 is $2,159,602,000.On average, 10 Wall Street analysts forecast ICUI's revenue for 2026 to be $55,415,596,208, with the lowest ICUI revenue forecast at $52,964,906,484, and the highest ICUI revenue forecast at $57,416,159,248. On average, 10 Wall Street analysts forecast ICUI's revenue for 2027 to be $57,866,285,932, with the lowest ICUI revenue forecast at $54,990,476,562, and the highest ICUI revenue forecast at $60,116,919,352.
In 2028, ICUI is forecast to generate $60,492,024,922 in revenue, with the lowest revenue forecast at $57,241,109,982 and the highest revenue forecast at $63,317,820,216.